PB1972: ASC4START: A PHASE IIIB, OPEN‐LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE.
| Autor: | Hochhaus, Andreas, Saussele, Susanne, Mahon, Francois‐Xavier, Pilipovic, Virginia, Zhang, Yifan, Schuld, Peter, Brümmendorf, Tim H |
|---|---|
| Zdroj: | HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text